Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Alzheimer's Disease

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 27 articles:
HTML format



Single Articles


    April 2020
  1. ABBASI J
    Alzheimer Blood Test Using Tau Biomarker Is in Development.
    JAMA. 2020;323:1336.
    PubMed    


    February 2020
  2. PATNODE CD, Perdue LA, Rossom RC, Rushkin MC, et al
    Screening for Cognitive Impairment in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2020;323:764-785.
    PubMed     Abstract available


  3. ABBASI J
    Ultrasound Brain Stimulation Piloted in Alzheimer Study.
    JAMA. 2020;323:499.
    PubMed    


  4. BORELLI CM, Grennan D, Muth CC
    Causes of Memory Loss in Elderly Persons.
    JAMA. 2020;323:486.
    PubMed    


    January 2020
  5. KUEHN BM
    In Alzheimer Research, Glucose Metabolism Moves to Center Stage.
    JAMA. 2020 Jan 8. pii: 2758712. doi: 10.1001/jama.2019.20939.
    PubMed    


    October 2019
  6. ARVANITAKIS Z, Shah RC, Bennett DA
    Diagnosis and Management of Dementia: Review.
    JAMA. 2019;322:1589-1599.
    PubMed     Abstract available


    July 2019
  7. HAMPTON T
    For Alzheimer Pathology, Light and Sound Stimulation May Hold Promise.
    JAMA. 2019;322:17-18.
    PubMed    


    June 2019
  8. WOLK D, Salloway S, Dickerson B
    Putting the New Alzheimer Disease Amyloid, Tau, Neurodegeneration (AT[N]) Diagnostic System to the Test.
    JAMA. 2019;321:2289-2291.
    PubMed    


    April 2019
  9. HAMPTON T
    Studies Further Support Transmissibility of Alzheimer Disease-Associated Proteins.
    JAMA. 2019;321:1243-1244.
    PubMed    


  10. RABINOVICI GD, Gatsonis C, Apgar C, Chaudhary K, et al
    Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.
    JAMA. 2019;321:1286-1294.
    PubMed     Abstract available


    December 2018
  11. GLAZNER G, Kaplan DB
    The Alzheimer's Poetry Project.
    JAMA. 2018;320:2294-2295.
    PubMed    


    November 2018
  12. KUEHN B
    Alzheimer Burden.
    JAMA. 2018;320:1851.
    PubMed    


    September 2018
  13. OSSENKOPPELE R, Rabinovici GD, Smith R, Cho H, et al
    Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.
    JAMA. 2018;320:1151-1162.
    PubMed     Abstract available


  14. ABBASI J
    Promising Results in 18-Month Analysis of Alzheimer Drug Candidate.
    JAMA. 2018;320:965.
    PubMed    


    June 2018
  15. SLOMSKI A
    Abeta-Clearing Drug Fails to Slow Alzheimer Disease.
    JAMA. 2018;319:2470.
    PubMed    


    March 2018
  16. ABBASI J
    Plasma Biomarkers Predict Brain Amyloid-beta Burden.
    JAMA. 2018;319:972.
    PubMed    


    January 2018
  17. ATRI A, Frolich L, Ballard C, Tariot PN, et al
    Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.
    JAMA. 2018;319:130-142.
    PubMed     Abstract available


  18. BENNETT DA
    Lack of Benefit With Idalopirdine for Alzheimer Disease: Another Therapeutic Failure in a Complex Disease Process.
    JAMA. 2018;319:123-125.
    PubMed    


    October 2017
  19. ABBASI J
    A Retinal Scan for Alzheimer Disease.
    JAMA. 2017;318:1314.
    PubMed    


  20. DONOHUE MC, Aisen PS
    Elevated Brain Amyloid in Cognitively Normal Individuals-Reply.
    JAMA. 2017;318:1393-1394.
    PubMed    


  21. GAO R, Chen C, Zhu T
    Elevated Brain Amyloid in Cognitively Normal Individuals.
    JAMA. 2017;318:1392-1393.
    PubMed    


    June 2017
  22. VISSER PJ, Tijms B
    Brain Amyloid Pathology and Cognitive Function: Alzheimer Disease Without Dementia?
    JAMA. 2017;317:2285-2287.
    PubMed    


  23. DONOHUE MC, Sperling RA, Petersen R, Sun CK, et al
    Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons.
    JAMA. 2017;317:2305-2316.
    PubMed     Abstract available


    May 2017
  24. SABAYAN B, Sorond F
    Reducing Risk of Dementia in Older Age.
    JAMA. 2017;317:2028.
    PubMed    


    April 2017
  25. GOTTESMAN RF, Schneider AL, Zhou Y, Coresh J, et al
    Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.
    JAMA. 2017;317:1443-1450.
    PubMed     Abstract available


    February 2017
  26. LYON J
    Alzheimer Outlook Far From Bleak.
    JAMA. 2017 Feb 15. doi: 10.1001/jama.2017.0276.
    PubMed    


    December 2016
  27. LYON J
    Study Suggests Alzheimer and Parkinson Disease Are Not Transmitted Through Blood Transfusion.
    JAMA. 2016 Dec 21. doi: 10.1001/jama.2016.16260.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: